Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04640623 |
|---|---|
| Brief Title: | A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy (SunRISe-1) |
| First Submitted : | November 20, 2020 |
| First Submitted that Met QC Criteria : | November 20, 2020 |
| First Posted : | November 23, 2020 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |